Project Grant R01AI191414
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Iowa a Project Grant totaling $427,625 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 1, 2026, through January 31, 2028. The award funds basic immunology research investigating the molecular mechanisms by which Tumor Necrosis Factor Receptor-Associated Factor 3 (TRAF3) regulates CD4+ T cell differentiation and function...
- Federal Project Grant Award Summary The University of Iowa received a $499,999 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 22, 2025, with a completion date of July 31, 2026. The grant funds biomedical research investigating how perinatal inflammation directs trained immunity in offspring, specifically examining the mechanisms through which chorioamnionitis—infection...
- Federal Project Grant Award Summary The University of Iowa received a $427,625 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 11, 2026, with completion scheduled for January 31, 2028. This award supports basic biomedical research focused on identifying novel molecular regulators of T follicular helper (TFH) cell differentiation. TFH cells are critical CD4+ T cell...
- Federal Grant Award Summary The University of Iowa received a $155,500 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective August 1, 2025, through July 31, 2027. The award funds research investigating age-associated, radiation-induced cardiopulmonary damage through examination of nitro-oxidative signaling and mitochondrial metabolism. The research employs genetically modified mice and...
- Federal Grant Award Summary The University of Iowa received a $769,414 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 9, 2025, with an ultimate completion date of June 30, 2030. This research award funds investigation into how the cellular protein SAMHD1 (sterile alpha motif and HD domain-containing protein 1) regulates innate immune responses during Human...
- Federal Grant Award Summary The University of Iowa received a $447,169 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 24, 2025, with completion targeted for January 31, 2027. The grant funds research into nanobody-mediated proteolysis of Aspergillus fumigatus transcription factors to advance understanding of fungal pathogenesis mechanisms. The project addresses a...
- Federal Project Grant Award Summary The University of Iowa received a $183,276 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 1, 2025, with completion scheduled for July 31, 2027. This award supports biomedical research investigating hemozoin and liver stage malaria vaccine efficacy. The research addresses a critical public health challenge, as malaria continues to cause...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Iowa a $661,693 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 16, 2025, through May 31, 2030. This research award supports fundamental scientific investigation into peptidoglycan crosslinking enzymes in Clostridioides difficile, an opportunistic pathogen responsible for hospital-acquired infectious diarrhea identified...
- Federal Project Grant Award Summary The University of Iowa received a $427,625 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 17, 2025, with a completion date of May 31, 2027. This research project investigates the mechanism of measles virus (MEV) transmission in human airway epithelial cells, specifically examining how MEV rapidly forms infectious centers through an...
- Federal Project Grant Award Summary The University of Iowa received a $427,627 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025, through June 30, 2027. This award funds biomedical research investigating the role of gamma herpesvirus—specifically Epstein-Barr virus (EBV)—in triggering or augmenting myelin autoimmunity relevant to multiple sclerosis (MS) etiology....
The University of Iowa received a $649,484 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 10, 2026, with completion scheduled for January 31, 2031. This research project investigates the impact of whole-body radiation exposure on pathogen-specific memory CD8 T cells, addressing a critical knowledge gap in understanding radiation-induced immune dysfunction. The research focuses on how accidental or deliberate radiation exposure affects pre-existing CD8 T cell memory populations—specifically examining both circulating memory CD8 T cells (TCM) and tissue-resident memory T cells (TRM)—to inform the development of medical countermeasures for radiation exposure victims. The project delivers fundamental biomedical research aimed at clarifying the mechanisms by which radiation disrupts immune system function, with particular emphasis on the longevity and protective capacity of pathogen and vaccine-induced CD8 T cell memory. By elucidating how radiation exposure compromises the body's ability to mount effective immune responses against re-infection, this research addresses an important public health priority and contributes to the scientific foundation necessary for developing therapeutic interventions for both accidental radiation exposures and deliberate radiation scenarios. The research is conducted at the University of Iowa's Iowa City campus and supports the broader federal research mission to advance knowledge of infectious and immunologic disease mechanisms.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $649.5k | 2/10/26 |